Related Experiment Video
Updated: Jun 9, 2026

07:14
Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
Published on: July 11, 2025
Reverse-benzamidine antimalarial agents: design, synthesis, and biological evaluation
Olivier Berger1, Sharon Wein, Jean-Frederic Duckert
1Institut des Biomolécules Max Mousseron UMR 5247 CNRS-Universités Montpellier I et II, Faculté de Pharmacie, 15 Av Ch Flahault, 34093 Montpellier cedex 5, France.
Bioorganic & Medicinal Chemistry Letters
|August 31, 2010
Summary
Researchers studied bis-N-alkylamidines and designed new reverse-benzamidine derivatives. Alkylamidine basicity, not lipophilicity, directly impacts antimalarial drug effectiveness.
Area of Science:
- Medicinal Chemistry
- Organic Chemistry
- Parasitology
Background:
- Development of novel choline analogs is crucial for therapeutic advancements.
- Bis-N-alkylamidines represent a class of compounds with potential biological activity.
- Understanding structure-activity relationships is key to designing effective drugs.
Purpose of the Study:
- To investigate the structure-activity relationships (RSA) of bis-N-alkylamidines.
- To design and synthesize a new series of reverse-benzamidine derivatives.
- To determine the influence of physicochemical properties on antimalarial potency.
Main Methods:
- Synthesis of novel reverse-benzamidine derivatives.
- Physicochemical characterization of synthesized compounds.
- Evaluation of antimalarial activity in vitro.
Main Results:
- A new series of reverse-benzamidine derivatives was successfully designed and synthesized.
- Basicity of alkylamidine compounds was identified as a critical factor for antimalarial activity.
- Lipophilicity showed a less direct correlation with antimalarial potency compared to basicity.
Conclusions:
- The basicity of alkylamidine derivatives is a key determinant of their antimalarial efficacy.
- Reverse-benzamidine structures offer a promising scaffold for developing new antimalarial agents.
- Further research into modulating basicity could lead to more potent antimalarial drugs.
More Related Videos
Related Concept Videos
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...

